239
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prevalence and Risk Factors of Comorbid Obesity in Chinese Patients with Bipolar Disorder

, , &
Pages 1459-1469 | Received 13 Feb 2023, Accepted 10 May 2023, Published online: 18 May 2023

References

  • Grande I, Berk M, Birmaher B, et al. Bipolar disorder. Lancet. 2016;387(10027):1561–1572. doi:10.1016/S0140-6736(15)00241-X
  • Vieta E, Salagre E, Grande I, et al. Early intervention in bipolar disorder. Am J Psychiatry. 2018;175(5):411–426. doi:10.1176/appi.ajp.2017.17090972
  • Bessonova L, Ogden K, Doane MJ, et al. The economic burden of bipolar disorder in the United States: a systematic literature review. ClinicoEconomics Outcomes Res. 2020;12:481–497. doi:10.2147/CEOR.S259338
  • Chan JKN, Wong CSM, Yung NCL, et al. Excess mortality and life-years lost in people with bipolar disorder: an 11-year population-based cohort study. Epidemiol Psychiatr Sci. 2021;30:e39. doi:10.1017/S2045796021000305
  • McElroy SL. Obesity in patients with severe mental illness: overview and management. J Clin Psychiatry. 2009;70(Suppl 3):12–21. doi:10.4088/JCP.7075su1c.03
  • Keck PE, McElroy SL. Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J Clin Psychiatry. 2003;64(12):1426–1435. doi:10.4088/JCP.v64n1205
  • Sicras A, Rejas J, Navarro R, et al. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord. 2008;10(5):607–616. doi:10.1111/j.1399-5618.2008.00599.x
  • Weber NS, Fisher JA, Cowan DN, et al. Psychiatric and general medical conditions comorbid with bipolar disorder in the national hospital discharge survey. Psychiatr Serv. 2011;62(10):1152–1158. doi:10.1176/ps.62.10.pss6210_1152
  • Kim B, Kim SJ, Son JI, et al. Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients. J Affect Disord. 2008;105(1–3):45–52. doi:10.1016/j.jad.2007.04.006
  • Menculini G, Verdolini N, Brufani F, et al. Comorbidities, depression severity, and circadian rhythms disturbances as clinical correlates of duration of untreated illness in affective disorders. Medicina. 2021;57:5.
  • Maina G, Salvi V, Vitalucci A, et al. Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder. J Affect Disord. 2008;110(1–2):149–155. doi:10.1016/j.jad.2007.12.233
  • Cole DP, Thase ME, Mallinger AG, et al. Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am J Psychiatry. 2002;159(1):116–121. doi:10.1176/appi.ajp.159.1.116
  • Bahrami S, Steen NE, Shadrin A, et al. Shared genetic loci between body mass index and major psychiatric disorders: a genome-wide association study. JAMA Psychiatry. 2020;77(5):503–512. doi:10.1001/jamapsychiatry.2019.4188
  • González-Muniesa P, Mártinez-González MA, Hu FB, et al. Obesity. Nat Rev Dis Primers. 2017;3:17034. doi:10.1038/nrdp.2017.34
  • Deng T, Lyon CJ, Bergin S, et al. Obesity, Inflammation, and Cancer. Annu Rev Pathol. 2016;11:421–449. doi:10.1146/annurev-pathol-012615-044359
  • Scherer PE, Hill JA. Obesity, diabetes, and cardiovascular diseases: a compendium. Circ Res. 2016;118(11):1703–1705. doi:10.1161/CIRCRESAHA.116.308999
  • Di Angelantonio E, Bhupathiraju SN, Gao P, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776–786. doi:10.1016/S0140-6736(16)30175-1
  • Preston SH, Vierboom YC, Stokes A. The role of obesity in exceptionally slow US mortality improvement. Proc Natl Acad Sci USA. 2018;115(5):957–961. doi:10.1073/pnas.1716802115
  • Rubin R. Profile: institute for health metrics and evaluation, WA, USA. Lancet. 2017;389(10068):493. doi:10.1016/S0140-6736(17)30263-5
  • Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021;9(6):373–392. doi:10.1016/S2213-8587(21)00045-0
  • Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022;133:155217. doi:10.1016/j.metabol.2022.155217
  • Fagiolini A, Kupfer DJ, Rucci P, et al. Suicide attempts and ideation in patients with bipolar I disorder. J Clin Psychiatry. 2004;65(4):509–514. doi:10.4088/JCP.v65n0409
  • Fagiolini A, Kupfer DJ, Houck PR, et al. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry. 2003;160(1):112–117. doi:10.1176/appi.ajp.160.1.112
  • Yi W, Wu H, Li R, et al. Prevalence and associated factors of obesity and overweight in Chinese patients with bipolar disorder. Front Psychiatry. 2022;13:984829. doi:10.3389/fpsyt.2022.984829
  • Chen W. Guidelines for medical nutrition treatment of overweight/obesity in China (2021). Asia Pac J Clin Nutr. 2022;31(3):450–482.
  • Onat A, Altay S, Karadeniz Y. Clinical significance and potential mechanism of discordance between apolipoprotein B and LDL-cholesterol. J Am Coll Cardiol. 2016;67(25):3023–3024. doi:10.1016/j.jacc.2016.02.083
  • Rajput-Williams J, Knott TJ, Wallis SC, et al. Variation of apolipoprotein-B gene is associated with obesity, high blood cholesterol levels, and increased risk of coronary heart disease. Lancet. 1988;2(8626–8627):1442–1446. doi:10.1016/S0140-6736(88)90930-0
  • Law A, Wallis SC, Powell LM, et al. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet. 1986;1(8493):1301–1303. doi:10.1016/S0140-6736(86)91222-5
  • Hassan NE, El-Masry SA, Zarouk WA, et al. Apolipoprotein B polymorphism distribution among a sample of obese Egyptian females with visceral obesity and its influence on lipid profile. J Genet Eng Biotechnol. 2015;13(2):177–183. doi:10.1016/j.jgeb.2015.09.005
  • Williams K, Sniderman AD, Sattar N, et al. Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2003;108(19):2312–2316. doi:10.1161/01.CIR.0000097113.11419.9E
  • Kimura Y, Tsukui D, Kono H. Uric acid in inflammation and the pathogenesis of atherosclerosis. Int J Mol Sci. 2021;22:22. doi:10.3390/ijms222212394
  • Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41(6):1287–1293. doi:10.1161/01.HYP.0000072820.07472.3B
  • Tamba S, Nishizawa H, Funahashi T, et al. Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Intern Med. 2008;47(13):1175–1180. doi:10.2169/internalmedicine.47.0603
  • Borghi C, Rosei EA, Bardin T, et al. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015;33(9):1729–1741; discussion 1741. doi:10.1097/HJH.0000000000000701
  • Kuwabara M, Hisatome I, Niwa K, et al. Uric acid is a strong risk marker for developing hypertension from prehypertension: a 5-year Japanese cohort study. Hypertension. 2018;71(1):78–86. doi:10.1161/HYPERTENSIONAHA.117.10370
  • Cheang C, Law S, Ren J, et al. Prevalence of hyperuricemia in patients with severe obesity and the relationship between serum uric acid and severe obesity: a decade retrospective cross-section study in Chinese adults. Front Public Health. 2022;10:986954. doi:10.3389/fpubh.2022.986954
  • Vander Schaft N, Brahimaj A, Wen KX, et al. The association between serum uric acid and the incidence of prediabetes and type 2 diabetes mellitus: the Rotterdam study. PLoS One. 2017;12(6):e0179482. doi:10.1371/journal.pone.0179482
  • Dai X, Yuan J, Yao P, et al. Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population. Eur J Epidemiol. 2013;28(8):669–676. doi:10.1007/s10654-013-9829-4
  • Albert U, De Cori D, Aguglia A, et al. Increased uric acid levels in bipolar disorder subjects during different phases of illness. J Affect Disord. 2015;173:170–175. doi:10.1016/j.jad.2014.11.005
  • Chen J, Chen H, Feng J, et al. Association between hyperuricemia and metabolic syndrome in patients suffering from bipolar disorder. BMC Psychiatry. 2018;18(1):390. doi:10.1186/s12888-018-1952-z
  • Lee NY, Kim SH, Cho B, et al. Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea’s general population. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(7):1243–1249. doi:10.1016/j.pnpbp.2010.06.029
  • Clemente-Postigo M, Queipo-Ortuño MI, Fernandez-Garcia D, et al. Adipose tissue gene expression of factors related to lipid processing in obesity. PLoS One. 2011;6(9):e24783. doi:10.1371/journal.pone.0024783
  • Klop B, Wouter Jukema J, Rabelink TJ, et al. A physician’s guide for the management of hypertriglyceridemia: the etiology of hypertriglyceridemia determines treatment strategy. Panminerva Med. 2012;54(2):91–103.
  • Zou Y, Sheng G, Yu M, et al. The association between triglycerides and ectopic fat obesity: an inverted U-shaped curve. PLoS One. 2020;15(11):e0243068. doi:10.1371/journal.pone.0243068
  • Slabber M, Barnard HC, Kuyl JM, et al. Effects of a low-insulin-response, energy-restricted diet on weight loss and plasma insulin concentrations in hyperinsulinemic obese females. Am J Clin Nutr. 1994;60(1):48–53. doi:10.1093/ajcn/60.1.48
  • Ludwig DS. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA. 2002;287(18):2414–2423. doi:10.1001/jama.287.18.2414
  • Lin HV, Accili D. Hormonal regulation of hepatic glucose production in health and disease. Cell Metab. 2011;14(1):9–19. doi:10.1016/j.cmet.2011.06.003
  • Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol. 2017;13(10):572–587. doi:10.1038/nrendo.2017.80
  • Lucan SC, DiNicolantonio JJ. How calorie-focused thinking about obesity and related diseases may mislead and harm public health. An alternative. Public Health Nutr. 2015;18(4):571–581. doi:10.1017/S1368980014002559
  • Taubes G. The science of obesity: what do we really know about what makes us fat? An essay by Gary Taubes. BMJ. 2013;346:f1050. doi:10.1136/bmj.f1050
  • Ludwig DS, Friedman MI. Increasing adiposity: consequence or cause of overeating? JAMA. 2014;311(21):2167–2168. doi:10.1001/jama.2014.4133
  • Chaput JP, Tremblay A, Rimm EB, et al. A novel interaction between dietary composition and insulin secretion: effects on weight gain in the Quebec family study. Am J Clin Nutr. 2008;87(2):303–309. doi:10.1093/ajcn/87.2.303
  • Ebbeling CB, Leidig MM, Feldman HA, et al. Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial. JAMA. 2007;297(19):2092–2102. doi:10.1001/jama.297.19.2092
  • Wang Y, Spolitu S, Zadroga JA, et al. Hepatocyte Rap1a contributes to obesity- and statin-associated hyperglycemia. Cell Rep. 2022;40(8):111259. doi:10.1016/j.celrep.2022.111259
  • van Winkel R, De Hert M, Van Eyck D, et al. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord. 2008;10(2):342–348. doi:10.1111/j.1399-5618.2007.00520.x
  • Regenold WT, Thapar RK, Marano C, et al. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord. 2002;70(1):19–26. doi:10.1016/S0165-0327(01)00456-6
  • Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry. 1999;156(9):1417–1420. doi:10.1176/ajp.156.9.1417
  • Yoo JJ, Cho EJ, Chung GE, et al. Nonalcoholic fatty liver disease is a precursor of new-onset metabolic syndrome in metabolically healthy young adults. J Clin Med. 2022;11:4. doi:10.3390/jcm11040935
  • Lorenzo C, Hanley AJ, Rewers MJ, et al. The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the insulin resistance atherosclerosis study. Diabetologia. 2013;56(4):746–757. doi:10.1007/s00125-012-2826-4
  • Laine S, Sjöros T, Vähä-Ypyä H, et al. Body adiposity, but not elements of objectively measured sedentary behavior or physical activity, is associated with circulating liver enzymes in adults with overweight and obesity. Front Endocrinol. 2021;12:655756. doi:10.3389/fendo.2021.655756
  • Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999–2004. Gastroenterology. 2007;133(6):1814–1820. doi:10.1053/j.gastro.2007.08.077
  • Tsai SY, Lee CH, Kuo CJ, et al. A retrospective analysis of risk and protective factors for natural death in bipolar disorder. J Clin Psychiatry. 2005;66(12):1586–1591. doi:10.4088/JCP.v66n1215